HAWKINS WILLIAM A 4

What Happened William A. Hawkins, a director of Biogen Inc. (BIIB), received a grant of 1,505 restricted stock units (RSUs) on June 9, 2026. The Form 4 reports the award with a price of $0.00 at grant (transaction code A). This is a grant of equity compensation rather than a market purchase or sale.

Key Details

• Transaction date: June 9, 2026; Form 4 filed June 11, 2026 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares granted: 1,505 RSUs; reported price at grant: $0.00.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Footnote: RSUs vest on the earlier of (i) the next annual meeting or (ii) the one‑year anniversary of the grant (June 9, 2026).
• No 10b5-1 plan, tax‑withholding, or sale information disclosed in this filing.

Context Restricted stock units are a common form of director compensation; they convert to shares if and when they vest. Grants like this are routine and reflect compensation rather than an outright market purchase or sale, so they should not be read as a direct buy/sell signal about future stock performance.